The Epigenetics of Exercise and Physical Activity in COPD
1 other identifier
observational
50
1 country
1
Brief Summary
This study seeks to examine genome-wide DNA methylation patterns associated with physical activity and exercise capacity from peripheral blood collected from participants with chronic obstructive pulmonary disease (COPD) before and after participation in a structured 9-week outpatient pulmonary rehabilitation program.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2018
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2018
CompletedFirst Submitted
Initial submission to the registry
May 1, 2018
CompletedFirst Posted
Study publicly available on registry
May 29, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2021
CompletedMay 30, 2018
May 1, 2018
2.8 years
May 1, 2018
May 25, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in DNA methylation patterns
Baseline patterns and changes over time after participation in exercise training
Baseline and 3-month follow up
Secondary Outcomes (2)
Change in 6MWD
Baseline and 3-month follow up
Change in average daily step count
Baseline and 3-month follow up
Eligibility Criteria
This study will recruit from Veterans referred to the VA Boston Pulmonary Rehabilitation Program who have a confirmed diagnosis of COPD.
You may qualify if:
- Age \>40 years
- Diagnosis of COPD (defined as an FEV1/FVC\<0.7 or evidence of emphysema on radiologist's read of a chest CT obtained in the course of patient's usual care)
- Referral to and participation in the VA Boston Pulmonary Rehabilitation program
You may not qualify if:
- Active or unstable cardiac disease
- Inability to ambulate \> 1 block
- Recent acute exacerbation of COPD (defined as new or increased dose of systemic steroids and/or antibiotics for pulmonary indications)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
VA Boston Healthcare System
Boston, Massachusetts, 02130, United States
Biospecimen
Peripheral blood and urine will be collected at 2 time points via venipuncture. Plasma and buffy coat will be extracted and stored for analysis at the conclusion of the study. Participation in this study will not impact the course of usual clinical care (observational study).
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Emily S Wan, MD,MPH
VA Boston Healthcare System
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- FED
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Physician and Principal Investigator
Study Record Dates
First Submitted
May 1, 2018
First Posted
May 29, 2018
Study Start
March 1, 2018
Primary Completion
December 31, 2020
Study Completion
June 30, 2021
Last Updated
May 30, 2018
Record last verified: 2018-05
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- 3 years
- Access Criteria
- Prospective researchers must complete VA-required trainings in HIPAA, information security, and CITI training.
Individual level data will be entered into an approved research repository behind the VA firewall. Data will be shared with qualified researchers (see below)